WB
GILD icon

West Bancorporation’s Gilead Sciences GILD Stock Holding History

West Bancorporation’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66
Closed -$4K – 149
2022
Q3 		$4K Hold
66
– – ﹤0.01% 239
2022
Q2 		$4K Hold
66
– – ﹤0.01% 258
2022
Q1 		$4K Hold
66
– – ﹤0.01% 293
2021
Q4 		$5K Buy
+66
New +$4.55K ﹤0.01% 283
2020
Q3 		$8K Hold
131
– – 0.01% 230
2020
Q2 		$10K Sell
131
-1,370
-91% -$105K 0.01% 222
2020
Q1 		$112K Sell
1,501
-118
-7% -$8.15K 0.16% 88
2019
Q4 		$105K Buy
+1,619
New +$105K 0.11% 105

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

West Bancorporation's GILD Position: Q4 2022 in Review

West Bancorporation sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 66 shares — an estimated $4K sold.

West Bancorporation first reported a position in GILD in Q4 2019 and held it in 8 quarters. The position peaked at $112K in Q1 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • West Bancorporation reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • West Bancorporation sold 66 Gilead Sciences shares in Q4 2022, an estimated $4K.
  • West Bancorporation first reported a position in Gilead Sciences in Q4 2019 and held it in 8 quarters.
  • West Bancorporation's Gilead Sciences position peaked at $112K in Q1 2020.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on West Bancorporation's 13F filing for Q4 2022, filed 30 Jan 2023.